1-[4-(4-Hydroxy-3-methoxy-phenyl)-3,6-dihydro-2H-pyridin-1-yl]-ethanone

ID: ALA110621

PubChem CID: 618934

Max Phase: Preclinical

Molecular Formula: C14H17NO3

Molecular Weight: 247.29

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(C2=CCN(C(C)=O)CC2)ccc1O

Standard InChI:  InChI=1S/C14H17NO3/c1-10(16)15-7-5-11(6-8-15)12-3-4-13(17)14(9-12)18-2/h3-5,9,17H,6-8H2,1-2H3

Standard InChI Key:  JXZNMXKUSHMRCH-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 18 19  0  0  0  0  0  0  0  0999 V2000
   -0.9583   -3.0292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9500   -1.8375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9583   -3.6292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9500   -1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4333   -2.1292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4333   -0.9375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4333   -0.3292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4333   -2.7292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4708   -2.7292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9500   -0.0292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4708   -2.1292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4375   -3.9375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4708   -0.9375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4708   -0.3375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0875   -0.0292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9583    0.5708    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4750   -3.9292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6042   -0.3250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2 11  1  0
  3  1  1  0
  4  2  1  0
  5  8  1  0
  6  4  2  0
  7  6  1  0
  8  1  1  0
  9  1  1  0
 10 14  1  0
 11  9  1  0
 12  3  2  0
 13  4  1  0
 14 13  2  0
 15  7  1  0
 16 10  1  0
 17  3  1  0
 18 15  1  0
  2  5  2  0
 10  7  2  0
M  END

Associated Targets(Human)

QDPR Tchem Dihydropteridine reductase (29 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Qdpr Dihydropteridine reductase (31 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 247.29Molecular Weight (Monoisotopic): 247.1208AlogP: 2.04#Rotatable Bonds: 2
Polar Surface Area: 49.77Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 9.94CX Basic pKa: CX LogP: 1.12CX LogD: 1.11
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.87Np Likeness Score: -0.02

References

1. Gessner W, Brossi A, Shen R, Abell CW..  (1985)  Synthesis and dihydropteridine reductase inhibitory effects of potential metabolites of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.,  28  (3): [PMID:3871859] [10.1021/jm00381a009]

Source